GeVIR Banner
Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
MUC6 ENST00000421673 99.30 49.47 77.60 0.11 0.66 0.37 0.12 2.02 0.56
C17orf77 ENST00000392620 99.31 98.33 99.86 0.11 0.21 0.12 0.12 0.14 0.04
ZNF284 ENST00000421176 99.31 91.26 97.83 0.11 0.23 0.09 0.12 0.34 0.04
ZNF562 ENST00000448622 99.32 60.85 83.43 0.11 0.56 0.33 0.12 1.41 0.40
TRIM64C ENST00000530230 99.32 83.76 94.31 0.11 0.28 0.10 0.12 0.47 0.12
APOL2 ENST00000249066 99.33 90.08 97.35 0.11 0.25 0.08 0.12 0.37 0.07
LILRA5 ENST00000301219 99.33 81.09 92.95 0.11 0.35 0.14 0.12 0.55 0.15
ZSCAN5A ENST00000587340 99.34 53.70 79.84 0.11 0.63 0.37 0.12 1.69 0.52
NAP1L6 ENST00000373518 99.34 98.37 99.99 0.11 0.21 0.13 0.12 0.14 0.04
MRGPRX4 ENST00000314254 99.35 98.69 99.91 0.11 0.18 0.12 0.12 0.15 0.04
NLRP4 ENST00000301295 99.35 40.95 72.91 0.11 0.61 0.40 0.12 1.79 0.81
AL357673.1 ENST00000536061 99.36 97.74 99.71 0.11 0.21 0.12 0.12 0.17 0.04
CD300A ENST00000360141 99.36 69.44 87.56 0.11 0.54 0.27 0.12 1.13 0.31
NPAP1 ENST00000329468 99.37 99.40 99.88 0.11 0.16 0.12 0.12 0.12 0.04
C4orf40 ENST00000344526 99.38 84.38 94.60 0.11 0.29 0.09 0.12 0.44 0.11
APOBEC3H ENST00000401756 99.38 50.73 78.31 0.11 0.63 0.38 0.12 1.94 0.54
FAM187B ENST00000324675 99.39 92.43 98.23 0.11 0.27 0.09 0.12 0.30 0.05
MAS1L ENST00000377127 99.39 99.83 99.98 0.11 0.17 0.13 0.12 0.11 0.04
TAS2R46 ENST00000533467 99.40 98.63 99.91 0.11 0.20 0.12 0.12 0.15 0.04
OBP2B ENST00000372034 99.40 84.57 94.72 0.11 0.29 0.09 0.12 0.42 0.11
TRIM22 ENST00000379965 99.41 56.00 81.07 0.11 0.49 0.39 0.12 1.56 0.49
PRAMEF7 ENST00000361079 99.41 90.85 97.71 0.11 0.25 0.09 0.12 0.35 0.05
ZNF195 ENST00000399602 99.42 70.59 88.16 0.11 0.51 0.23 0.12 1.09 0.30
SATL1 ENST00000509231 99.42 82.96 93.96 0.11 0.30 0.09 0.12 0.49 0.11
SCGB1D2 ENST00000244926 99.43 77.18 91.25 0.11 0.43 0.15 0.12 0.78 0.18

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.